VITL Vital Farms, Inc.
Food and Kindred Products · Nasdaq · SEC CIK 1579733 · Fiscal year ends 12/27
Financial factors as of 2026-09-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.2%
TTM net income YoY-137.5%
TTM EPS YoY-142.4%
Revenue 3-yr CAGR18.8%
Net income 3-yr CAGR—
Margins
Gross margin24.4%
Operating margin-3.8%
Net margin-3.0%
FCF margin-18.5%
EBITDA margin-2.4%
Returns
ROE-7.4%
ROA-4.3%
ROIC (approx.)-8.2%
Asset turnover1.42x
Leverage & solvency
Liabilities / assets50.8%
Debt / equity0.42x
Current ratio1.56x
Interest coverage-7.67x
Cash quality & payout
Operating cash flow / net income2.14x
Accruals ratio4.9%
Payout ratio—
Capex / revenue12.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-27 | 2026Q22026-06-28 | 2026Q12026-03-29 | 2025Q4*2025-12-28 | 2025Q32025-09-28 | 2025Q22025-06-29 | 2025Q12025-03-30 | 2024Q4*2024-12-29 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $182.16M | $166.03M | $187.16M | $213.55M | $198.94M | $184.77M | $162.19M | $165.99M |
| Cost of revenue | $140.02M | $155.10M | $134.15M | $137.13M | $123.97M | $112.98M | $99.68M | $106.11M |
| Gross profit | $42.14M | $10.93M | $53.01M | $76.42M | $74.96M | $71.78M | $62.51M | $59.88M |
| SG&A expense | $38.14M | $40.38M | $44.36M | $44.14M | $44.39M | $38.99M | $31.91M | $37.37M |
| Operating income | -$7.68M | -$40.15M | -$2.33M | $21.41M | $21.40M | $23.80M | $21.77M | $13.00M |
| Interest expense | $2.93M | $421,000 | $190,000 | $208,000 | $213,000 | $218,000 | $234,000 | $239,000 |
| Pretax income | -$9.23M | -$40.79M | -$1.86M | $22.42M | $21.97M | $24.53M | $22.34M | $14.32M |
| Income tax | -$2.77M | -$9.72M | -$337,000 | $6.10M | $5.55M | $7.89M | $5.44M | $3.74M |
| Net income | -$6.46M | -$31.07M | -$1.52M | $16.32M | $16.42M | $16.64M | $16.90M | $10.58M |
| EBITDA | -$4.74M | -$37.88M | $268,000 | $24.00M | $23.44M | $26.20M | $23.99M | $15.28M |
| EPS (basic) | -0.15 | -0.72 | -0.03 | — | 0.37 | 0.37 | 0.38 | — |
| EPS (diluted) | -0.15 | -0.72 | -0.03 | — | 0.36 | 0.36 | 0.37 | — |
| Weighted avg. shares (diluted) | 42.93M | 42.94M | 44.59M | — | 46.21M | 45.80M | 45.80M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $83.95M | $21.24M | $36.62M | $48.83M | $93.80M | $108.22M | $156.31M | $150.60M |
| Receivables | $60.62M | $50.70M | $51.43M | $67.85M | $58.25M | $68.41M | $51.88M | $54.34M |
| Inventory | $50.25M | $73.89M | $90.22M | $66.50M | $51.81M | $42.71M | $34.52M | $23.67M |
| Current assets | $214.03M | $162.89M | $209.18M | $262.55M | $271.97M | $275.21M | $259.83M | $246.04M |
| PP&E, net | $195.68M | $192.22M | $177.91M | $160.60M | $121.08M | $111.16M | $81.45M | $84.52M |
| Goodwill | $3.86M | $3.86M | $3.86M | $3.86M | $3.86M | $3.86M | $3.86M | $3.86M |
| Total assets | $570.15M | $502.08M | $492.64M | $518.74M | $481.50M | $430.75M | $376.89M | $359.33M |
| Current liabilities | $136.93M | $147.58M | $118.42M | $121.58M | $102.59M | $110.85M | $77.51M | $78.53M |
| Short-term debt | $1.25M | — | — | $0 | — | — | — | — |
| Long-term debt | $116.39M | $30.00M | — | $0 | — | — | — | — |
| Total debt | $117.64M | $30.00M | — | $0 | — | — | — | — |
| Total liabilities | $289.84M | $218.43M | $161.74M | $167.48M | $150.29M | $120.97M | $87.98M | $90.03M |
| Shareholders' equity | $280.31M | $283.65M | $330.91M | $351.26M | $331.22M | $309.78M | $288.90M | $269.30M |
| Net debt | $33.68M | $8.76M | — | -$48.83M | — | — | — | — |
| Shares outstanding | 42.94M | 42.93M | 43.98M | 44.80M | 44.77M | 44.66M | 44.50M | 44.04M |
| Cash flow statement | ||||||||
| Operating cash flow | -$8.53M | -$27.36M | -$18.55M | $5.78M | $23.42M | -$761,000 | $5.27M | $14.78M |
| Capital expenditure | $14.27M | $16.70M | $20.76M | $37.93M | $34.03M | $6.87M | $3.13M | $18.16M |
| Free cash flow | -$22.79M | -$44.06M | -$39.31M | -$32.15M | -$10.61M | -$7.63M | $2.15M | -$3.38M |
| Investing cash flow | -$14.81M | -$1.67M | $29.28M | -$49.92M | -$38.43M | -$47.51M | $1.60M | -$15.38M |
| Financing cash flow | $86.05M | $13.64M | -$22.93M | -$829,000 | $579,000 | $187,000 | -$1.17M | $1.67M |
| Depreciation & amortization | $2.95M | $2.27M | $2.60M | $2.59M | $2.04M | $2.40M | $2.22M | $2.28M |
| Stock-based compensation | $3.12M | -$1.38M | $2.76M | $3.26M | $3.24M | $3.03M | $2.85M | $2.70M |
| Share buybacks | -$150,000 | $15.15M | $20.00M | — | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 32 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.